tiprankstipranks
Advertisement
Advertisement

AmplifyMD Adds Former Jefferson Health and Providence CEOs to Steer Post-Series B Growth

AmplifyMD Adds Former Jefferson Health and Providence CEOs to Steer Post-Series B Growth

New updates have been reported about AmplifyMD.

Meet Samuel – Your Personal Investing Prophet

AmplifyMD has strengthened its governance and strategic bench by appointing former Jefferson Health CEO Stephen K. Klasko, MD, MBA, to its board of directors and Providence CEO Emeritus Rod Hochman, MD, as a strategic advisor, moves that align closely with the company’s post-Series B expansion plans. The AI-enabled multispecialty virtual care platform, which recently closed a $20 million Series B round led by Forerunner Ventures with participation from Memorial Hermann Health System, Greylock, F-Prime, and Tau Ventures, is positioning itself as core infrastructure for health systems looking to scale specialist coverage through integrated, AI-driven virtual care embedded in the electronic health record. CEO and co-founder Meena Mallipeddi said the new appointments come as health systems shift from ad hoc telehealth tools to enterprise-level virtual care models that address physician shortages and workforce constraints by reconfiguring specialist services as always-on, system-wide capabilities.

Klasko, a healthcare futurist and former president and CEO of Thomas Jefferson University and Jefferson Health who now serves as Executive in Residence at General Catalyst, framed AmplifyMD’s value proposition as transforming specialty coverage from a staffing problem into EHR-integrated infrastructure, calling it the type of solution he wished he had as a health system CEO. Hochman, who led Providence for more than a decade and previously chaired the American Hospital Association, highlighted the need for scalable mechanisms to extend clinical expertise and praised AmplifyMD’s approach of using deep integration and automation to turn virtual coverage into an operational model rather than a standalone tool, supporting the company’s planned national rollout. With these additions to its board and advisory team, AmplifyMD is better positioned to win health system partnerships seeking resilient specialty care models, and the appointments underscore a broader market view that AI, workflow automation, and tight EHR integration are now baseline requirements for virtual care to deliver meaningful operational and financial impact across emergent, acute, outpatient, and post-acute settings.

Disclaimer & DisclosureReport an Issue

1